###begin article-title 0
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
Common Variants within MECP2 Confer Risk of Systemic Lupus Erythematosus
###end article-title 0
###begin p 1
Conceived and designed the experiments: JH AS KK. Performed the experiments: RW KK. Analyzed the data: AS SN SH JK. Contributed reagents/materials/analysis tools: GG JH JJ RK RS TV SB MA CC. Wrote the paper: AS.
###end p 1
###begin p 2
###xml 211 216 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 462 467 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 583 588 583 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 475 483 <span type="species:ncbi:9606">patients</span>
Systemic lupus erythematosus (SLE) is a predominantly female autoimmune disease that affects multiple organ systems. Herein, we report on an X-chromosome gene association with SLE. Methyl-CpG-binding protein 2 (MECP2) is located on chromosome Xq28 and encodes for a protein that plays a critical role in epigenetic transcriptional regulation of methylation-sensitive genes. Utilizing a candidate gene association approach, we genotyped 21 SNPs within and around MECP2 in SLE patients and controls. We identify and replicate association between SLE and the genomic element containing MECP2 in two independent SLE cohorts from two ethnically divergent populations. These findings are potentially related to the overexpression of methylation-sensitive genes in SLE.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 261 264 261 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Petri1">[1]</xref>
###xml 502 505 502 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Sawalha1">[2]</xref>
###xml 562 567 562 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAL</italic>
###xml 577 583 577 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF7</italic>
###xml 592 596 592 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRF1</italic>
###xml 612 618 612 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD40LG</italic>
###xml 759 762 759 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Richardson1">[3]</xref>
###xml 764 767 764 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Oelke1">[4]</xref>
###xml 769 772 769 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Kaplan1">[5]</xref>
###xml 774 777 774 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Lu1">[6]</xref>
###xml 843 846 843 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Richardson2">[7]</xref>
###xml 912 915 912 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Yung1">[8]</xref>
###xml 1071 1074 1071 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Deng1">[9]</xref>
###xml 1172 1175 1172 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Sawalha1">[2]</xref>
###xml 1177 1180 1177 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Lu1">[6]</xref>
###xml 1335 1339 1335 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Bird1">[10]</xref>
###xml 1692 1696 1692 1696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Jones1">[11]</xref>
###xml 1793 1797 1793 1797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Kimura1">[12]</xref>
###xml 661 669 <span type="species:ncbi:9606">patients</span>
###xml 907 911 <span type="species:ncbi:10090">mice</span>
Systemic lupus erythematosus (SLE) is a debilitating autoimmune disease that affects multiple organs and is associated with significant morbidity and mortality. The disease predominantly affects females with a female to male ratio ranging between 4.3-13.6 to 1 [1]. The etiology of SLE remains incompletely understood, although a number of genetic and environmental factors have been implicated. Strong evidence supports an important role for abnormal T cell DNA methylation in the pathogenesis of SLE [2]. The expression of methylation sensitive genes, such as ITGAL (CD11a), TNFSF7 (CD70), PRF1 (perforin) and CD40LG (CD40L), is increased in T cells from SLE patients, similar to normal T cells treated with DNA methylation inhibitors such as 5-azacytidine [3], [4], [5], [6]. Indeed, 5-azacytidine treated T cells are autoreactive in vitro [7], and produce a SLE-like disease upon adoptive transfer into mice [8]. In active SLE T cells, the expression of DNA methyltransferase 1 (DNMT1), the main enzyme that maintains DNA methylation during cell division, is reduced [9], and the promoter sequences of the aforementioned methylation-sensitive genes are hypomethylated [2], [6]. DNA methylation suppresses gene expression via several mechanisms including the inability of transcription factors to bind methylated promoter sequences [10]. Methyl-CpG-binding protein 2 (MECP2) plays a critical role in this process. MECP2 binds methylcytosine residues and recruits histone deacetylase enzymes, which by deacetylating histone residues, increase the charge attraction between DNA and histone proteins and induce a chromatin configuration that is inaccessible for the transcriptional machinery [11]. Further, DNMT1 associates with and seems to require MECP2 in order to maintain DNA methylation [12].
###end p 4
###begin p 5
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 238 242 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-MiltenbergerMiltenyi1">[13]</xref>
###xml 494 498 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-MiltenbergerMiltenyi1">[13]</xref>
###xml 572 575 536 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Sawalha1">[2]</xref>
###xml 670 674 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Jones1">[11]</xref>
###xml 681 686 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 846 851 810 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 39 42 <span type="species:ncbi:9606">man</span>
###xml 907 915 <span type="species:ncbi:9606">patients</span>
MECP2 is located on chromosome Xq28 in man and contains four exons. It is approximately76 kb in length and is characterized by the presence of a very large intron 2 (approximately60 kb) and a highly conserved 3' UTR (approximately8.5 kb) [13]. The gene encodes a 486 amino acid chromatin-associated protein that consists of three domains; a methyl-binding domain, a transcription repression domain, and a third domain on the C-terminal region that has not been fully functionally characterized [13]. The facts that DNA methylation sensitive genes are overexpressed in SLE [2], and that MECP2 is critical in the transcriptional suppression of methylation sensitive genes [11], make MECP2 an attractive candidate gene for SLE. Using a candidate gene approach and a case-control genetic association study, we report herein on the association of the MECP2 gene region with SLE in two independent cohorts of SLE patients and controls.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 174 181 174 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001727-t001">Table 1</xref>
###xml 383 390 383 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001727-t002">Table 2</xref>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 491 498 491 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001727-t002">Table 2</xref>
###xml 503 509 503 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001727-g001">Fig. 1</xref>
###xml 595 596 595 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 658 659 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 710 711 710 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 765 766 765 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 896 897 896 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1018 1022 1018 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Barrett1">[14]</xref>
###xml 1032 1036 1032 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Purcell1">[15]</xref>
###xml 1098 1105 1098 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001727-t003">Table 3</xref>
###xml 1466 1473 1466 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001727-t003">Table 3</xref>
###xml 1583 1590 1583 1590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001727-t004">Table 4</xref>
###xml 45 53 <span type="species:ncbi:9606">patients</span>
###xml 571 579 <span type="species:ncbi:9606">patients</span>
###xml 1209 1217 <span type="species:ncbi:9606">patients</span>
###xml 1393 1401 <span type="species:ncbi:9606">patients</span>
We initially genotyped 628 Korean female SLE patients and 736 healthy female Korean controls across 21 single nucleotide polymorphisms (SNPs) located within or around MECP2 (Table 1). Nine SNPs had a minor allele frequency of more than 5% in our Korean cohort and were used for further analysis. All 9 SNPs were within expected Hardy-Weinberg proportions in both cases and controls (Table 2). Eight out of the nine SNPs are within the MECP2 gene and showed significant association with SLE (Table 2 and Fig. 1). The SNP having the strongest association in the Korean SLE patients is rs17435 (Chi2 = 22.83, OR = 1.58, p = 0.0000018) followed by rs1734787 (Chi2 = 21.58, OR = 1.55, p = 0.0000034), rs1734792 (Chi2 = 20.68, OR = 1.53, p = 0.0000054) and rs1734791 (Chi2 = 18.70, OR = 1.51, p = 0.000015). The SNPs rs1734787, rs1734792, and rs1734791 are all in linkage disequilibrium with rs17435 (r2 = 0.88, 0.92, and 0.86, respectively). We next performed haplotype-based association test using Haploview 3.32 software [14] and WHAP [15]. Three haplotypes (with a frequency of >1%) were identified (Table 3). The haplotype "ACTGCAAA" was identified as a disease risk haplotype with a frequency of 82.3% in SLE patients compared to 75.3% in normal healthy controls (OR = 1.53, p = 0.000013). On the other hand, the haplotype "GGAAATCG" is a protective haplotype with a frequency of 16.8% in SLE patients and 23.4% in normal healthy controls (OR = 0.66, p = 0.000027) (Table 3). Frequencies of the homozygous risk genotypes in the haplotype-forming SNPs were analyzed and summarized in Table 4.
###end p 7
###begin title 8
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
Allelic association results and linkage disequilibrium (LD) plot of the chromosome Xq28 region around the MECP2 gene.
###end title 8
###begin p 9
The allelic association p values of the SNPs analyzed are shown in the Korean cohort included in this study.
###end p 9
###begin title 10
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 42 50 <span type="species:ncbi:9606">patients</span>
SNPs genotyped in the MECP2 region in SLE patients and controls
###end title 10
###begin title 11
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Allele frequencies of SNPs in the MECP2 gene region genotyped in Korean SLE patients and that have a minor allele frequency of >0.05
###end title 11
###begin p 12
OR, odds ratio; CI, confidence interval; HWE, Hardy-Weinberg equilibrium.
###end p 12
###begin p 13
###xml 38 46 <span type="species:ncbi:9606">patients</span>
A total of 628 independent female SLE patients and 736 healthy unrelated female controls were genotyped
###end p 13
###begin title 14
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
MECP2 haplotype frequencies in the Korean SLE patients and controls.
###end title 14
###begin p 15
OR, odds ratio; CI, confidence interval.
###end p 15
###begin title 16
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Frequencies of homozygous risk allele genotypes in Korean SLE patients compared to controls.
###end title 16
###begin p 17
OR, odds ratio; CI, confidence interval.
###end p 17
###begin p 18
###xml 38 46 <span type="species:ncbi:9606">patients</span>
A total of 628 independent female SLE patients and 736 healthy unrelated female controls were genotyped
###end p 18
###begin p 19
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 204 211 204 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001727-t001">Table 1</xref>
###xml 509 516 509 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001727-t005">Table 5</xref>
###xml 521 527 521 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001727-g002">Fig. 2</xref>
###xml 991 998 991 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001727-t006">Table 6</xref>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
###xml 300 308 <span type="species:ncbi:9606">patients</span>
###xml 410 418 <span type="species:ncbi:9606">patients</span>
###xml 642 650 <span type="species:ncbi:9606">patients</span>
###xml 870 878 <span type="species:ncbi:9606">patients</span>
###xml 1046 1054 <span type="species:ncbi:9606">patients</span>
To replicate our initial results, we next genotyped 1080 European-derived independent SLE patients and 1080 healthy unrelated controls matched for sex and race using the same 21 SNPs in the MECP2 region (Table 1). Fifteen SNPs had a minor allele frequency of more than 5% in our European-derived SLE patients and controls and were used for subsequent analysis. All SNPs that were associated with SLE in Korean patients showed significant association with the same risk alleles in the European-derived cohort (Table 5 and Fig. 2). Similarly, the association with these SNPs is confirmed when only analyzing females in the European-derived SLE patients and controls, with the strongest association observed in rs1734787, rs17435, rs1734791, and rs1734792 (p values = 0.0016, 0.0017, 0.0020, and 0.0022, respectively). Our haplotype analysis in female European-derived SLE patients and controls also identified 3 haplotypes with the same risk and protective haplotypes as in the Korean cohort (Table 6). Subset analysis of male European-derived SLE patients and controls was not possible due to small sample size.
###end p 19
###begin title 20
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
Allelic association results and linkage disequilibrium (LD) plot of the chromosome Xq28 region around the MECP2 gene.
###end title 20
###begin p 21
The allelic association p values of the SNPs analyzed are shown in the European-derived cohort included in this study.
###end p 21
###begin title 22
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Allele frequencies of MECP2 SNPs in European-derived SLE patients and controls
###end title 22
###begin p 23
OR, odds ratio; CI, confidence interval; HWE, Hardy-Weinberg equilibrium.
###end p 23
###begin p 24
A total of 1080 independent cases and 1080 healthy unrelated controls matched for race and sex were genotyped
###end p 24
###begin title 25
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
MECP2 haplotype frequencies in the European-derived female SLE patients and controls.
###end title 25
###begin p 26
OR, odds ratio; CI, confidence interval.
###end p 26
###begin p 27
The impact of hidden population stratification on our association study was assessed by genomic control (GC) by estimating the inflation factor (lambda) in the samples. We estimated lambda = 1.06 in Korean and 1.08 in European-derived samples, hence no significant population stratification was detected. These results are also corroborated with our population structure estimates; one-population model (homogeneous population) fit better than a two-population model (admixture) for both cohorts.
###end p 27
###begin title 28
Discussion
###end title 28
###begin p 29
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Bird2">[16]</xref>
###xml 283 288 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 391 396 391 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 631 633 631 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 641 643 641 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 651 653 651 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 665 667 665 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 682 689 682 689 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 7</bold>
###xml 682 689 682 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001727-t007"><bold>Table 7</bold></xref>
###xml 752 757 752 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 328 336 <span type="species:ncbi:9606">patients</span>
###xml 434 442 <span type="species:ncbi:9606">patients</span>
###xml 929 935 <span type="species:ncbi:9606">people</span>
DNA methylation plays a critical role in tissue differentiation, imprinting, transcriptional suppression of parasitic DNA, silencing of transcriptional "noise", and X-chromosome inactivation [16]. Utilizing a candidate gene approach, we first identified significant association with MECP2 SNPs and SLE in a cohort of Korean SLE patients and controls. We next replicated the association with MECP2 SNPs in an independent cohort of SLE patients and controls of European descent. Indeed, the disease-associated alleles in rs17435, rs1734787, rs1734792, and rs1734791 (T, C, A, and A respectively) have meta-analysis p values of 1.2x10-8, 1.6x10-8, 3.3x10-8, and 7.2x10-8 respectively (Table 7). Interestingly, the disease associated alleles in these four MECP2 SNPs are approximately4 times more common in Korean as compared to European-derived controls. This might suggest a possible explanation for the higher frequency of SLE in people of Asian descent as compared to Europeans.
###end p 29
###begin title 30
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
Meta-analysis for risk alleles in SLE-associated MECP2 SNPs in Korean and European-derived cohorts
###end title 30
###begin p 31
OR, odds ratio; CI, confidence interval
###end p 31
###begin p 32
###xml 233 237 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Leonard1">[17]</xref>
###xml 309 314 297 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 320 324 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Amir1">[18]</xref>
###xml 447 451 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Guy1">[19]</xref>
###xml 453 457 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Shahbazian1">[20]</xref>
###xml 501 505 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Guy2">[21]</xref>
###xml 539 544 527 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 627 631 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Shibayama1">[22]</xref>
###xml 719 723 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Francke1">[23]</xref>
###xml 846 850 834 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Klose1">[24]</xref>
###xml 1016 1020 1004 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Young1">[25]</xref>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 419 427 <span type="species:ncbi:9606">patients</span>
###xml 691 699 <span type="species:ncbi:9606">patients</span>
MECP2 has been extensively studied in the setting of mental retardation and, particularly, Rett syndrome, an X-linked neurodevelopmental disease that has a cumulative incidence of approximately1/10,000 females by the age of 12 years [17]. In the majority of cases, this syndrome is caused by mutations in the MECP2 gene [18]. MECP2-deficient mice demonstrate clinical neurological findings similar to those observed in patients with Rett syndrome [19], [20], which can be reversed by MECP2 expression [21]. More recently, mutations in the MECP2 gene have been recognized in a number of other neuropsychiatric illnesses as well [22]. Identifying MECP2 regulated genes had been a challenge in patients with Rett syndrome [23]. Recent studies suggest that MECP2 binding to DNA is selective and requires A/T sequences adjacent to methylated CG sites [24]. In addition to its role in transcriptional regulation, MECP2 interacts with the RNA-binding protein Y box-binding protein 1 (YB-1) and plays a role in RNA splicing [25].
###end p 32
###begin p 33
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK1</italic>
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK1</italic>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK1</italic>
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK1</italic>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Gan1">[26]</xref>
Another interesting gene that is in close proximity to MECP2 is IRAK1 (Interleukin-1 receptor-associated kinase1). Both MECP2 and IRAK1 are on the same haplotype block in combined Japanese and Chinese individuals genotyped in the International HapMap Project (). Moreover, this haplotype block harbors only MECP2 and IRAK1 genes. The pivotal role of IRAK1 in Toll-like receptor signaling and innate immune response [26] makes this an important candidate gene for SLE.
###end p 33
###begin p 34
###xml 623 627 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Mohandas1">[27]</xref>
###xml 677 680 677 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Sawalha1">[2]</xref>
###xml 948 953 948 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD40L</italic>
###xml 990 993 990 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Lu1">[6]</xref>
###xml 150 158 <span type="species:ncbi:9606">patients</span>
###xml 722 730 <span type="species:ncbi:9606">patients</span>
###xml 744 752 <span type="species:ncbi:9606">patients</span>
###xml 981 989 <span type="species:ncbi:9606">patients</span>
We report on an X-chromosome association in SLE. A role for an X-chromosome gene in this predominantly female disease has long been anticipated. Male patients with Klinefelter's syndrome (47,XXY) have similar risk to develop SLE compared to females (46,XX) (Scofield RH, et al Arthritis and Rheumatism 2003; 48:S383) . Possible explanations for the suggested gene-dose effect are the presence of a SLE susceptibility gene(s) on the X-chromosome, or the overexpression of an X-chromosome gene as a result of loss of random X-chromosome inactivation, or both. X-chromosome inactivation is largely mediated by DNA methylation [27], and DNA methylation is defective in SLE T cells [2]. Hence, X-chromosome genes in SLE female patients and SLE male patients with Klinefelter's syndrome are available for transcription from both copies on the two X-chromosomes. This mechanism is suggested to explain the observed overexpression of the X-chromosome gene CD40L in T cells from female SLE patients [6]. Our findings provide evidence for SLE association with an X-chromosome region harboring two genes that are intimately involved in regulating the expression of methylation-sensitive genes and in innate immune response.
###end p 34
###begin p 35
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 440 448 <span type="species:ncbi:9606">patients</span>
In summary, the finding of strong association between the X-chromosome region harboring MECP2 and SLE suggests an important role for genetic and epigenetic interactions in the pathogenesis of this disease. This might provide more insight for the predominance of SLE in females and suggests a novel mechanism to explain the observed overexpression of methylation-sensitive genes in SLE T cells and the resulting T cell autoreactivity in SLE patients.
###end p 35
###begin title 36
Materials and Methods
###end title 36
###begin title 37
###xml 4 12 <span type="species:ncbi:9606">patients</span>
SLE patients and controls
###end title 37
###begin p 38
###xml 11 19 <span type="species:ncbi:9606">patients</span>
###xml 126 134 <span type="species:ncbi:9606">patients</span>
###xml 275 283 <span type="species:ncbi:9606">patients</span>
###xml 351 359 <span type="species:ncbi:9606">patients</span>
Korean SLE patients and controls were recruited at the Hospital for Rheumatic Diseases, Hanyang University, Seoul, Korea. All patients were of Korean descent and met the 1997 American College of Rheumatology SLE classification criteria. A total of 628 independent female SLE patients and 736 healthy unrelated female controls were studied. No two SLE patients or two controls are blood relatives to avoid intrafamilial correlation bias.
###end p 38
###begin p 39
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 446 454 <span type="species:ncbi:9606">patients</span>
Another independent cohort of SLE patients of European descent was studied. This cohort consisted of 1080 independent cases and 1080 healthy unrelated controls matched for race and sex and recruited in the SLE genetics studies at the Oklahoma Medical Research Foundation as well as from collaborators in the United States, United Kingdom, and Sweden. This cohort included 928 females and 152 males in each of the case and control groups. All SLE patients met the 1997 American College of Rheumatology SLE classification criteria.
###end p 39
###begin p 40
###xml 189 201 <span type="species:ncbi:9606">Participants</span>
The study was approved by the Institutional Review Boards of Hanyang University Medical Center, University of Oklahoma Health Sciences Center, and the Oklahoma Medical Research Foundation. Participants in the study gave written informed consent for the genotyping.
###end p 40
###begin title 41
Genotyping
###end title 41
###begin p 42
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 49 56 49 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001727-t001">Table 1</xref>
###xml 256 261 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 326 331 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
Twenty one SNPs within or around the MECP2 gene (Table 1) were genotyped on an Illumina BeadStation 500GX instrument using Illumina Infinum II genotyping assays following manufacturer's recommendations. The SNPs were selected to cover the entire length of MECP2 and the immediate genetic regions in both the 5' and 3' ends of MECP2. SNPs were selected from the published SNP databases (). In general, we selected SNPs that have been validated by at least two groups, that have a minor allele frequency of >/=5%, and that had been tested successfully on the Illumina genotyping platform that we used in our study. Genotyping data were only used from samples with a call rate greater than 90% of the SNPs screened (98.05% of the samples). The average call rate for all samples was 97.18%.
###end p 42
###begin title 43
Data analysis
###end title 43
###begin p 44
###xml 704 708 704 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Barrett1">[14]</xref>
###xml 822 826 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Barrett1">[14]</xref>
###xml 836 840 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001727-Purcell1">[15]</xref>
###xml 1042 1043 1042 1043 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
A population-based case-control statistical design was employed. For each tested SNP, the quality of the genotyping data was assessed by predetermined quality control inclusion criteria (MAF>5%, SNP call rate>90%, and HWE p value>0.01 among the controls). A Pearson's Chi square was calculated for the frequency of allele associations in cases and controls. P values of <0.05 were considered statistically significant. Odds ratios were calculated under the assumption of normality. Fisher's exact test was used to test for deviation from Hardy-Weinberg equilibrium in the genotyped SNPs in the cases and controls. Permutation p values were calculated to correct for multiple testing using Haploview 3.32 [14]. Haplotype frequencies were estimated using the expectation-maximization algorithm implemented in Haploview 3.32 [14] and WHAP [15]. Haplotype-based association analysis was used to perform regression-based omnibus haplotype frequency tests and haplotype-specific tests, implemented in WHAP. We also used pair-wise SNP correlation (r2) structure between the two populations to identify the minimum haplotype length which could carry the risk of SLE development. To control for possible confounding due to population stratification, we used genomic control (GC) as well as structured association analysis. A panel of 63 randomly chosen "null" SNPs genotyped on the same Illumina SNP platform was used for GC and for estimating hidden population structure.
###end p 44
###begin title 45
References
###end title 45
###begin article-title 46
Epidemiology of systemic lupus erythematosus.
###end article-title 46
###begin article-title 47
DNA methylation in the pathogenesis of systemic lupus erythematosus.
###end article-title 47
###begin article-title 48
###xml 100 108 <span type="species:ncbi:9606">patients</span>
Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus.
###end article-title 48
###begin article-title 49
Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors.
###end article-title 49
###begin article-title 50
Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells.
###end article-title 50
###begin article-title 51
###xml 58 63 <span type="species:ncbi:9606">women</span>
Demethylation of CD40LG on the inactive X in T cells from women with lupus.
###end article-title 51
###begin article-title 52
Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells.
###end article-title 52
###begin article-title 53
Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo.
###end article-title 53
###begin article-title 54
###xml 115 123 <span type="species:ncbi:9606">patients</span>
Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients.
###end article-title 54
###begin article-title 55
Methylation-induced repression-belts, braces, and chromatin.
###end article-title 55
###begin article-title 56
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.
###end article-title 56
###begin article-title 57
Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1.
###end article-title 57
###begin article-title 58
###xml 35 40 <span type="species:ncbi:9606">human</span>
Mutations and polymorphisms in the human methyl CpG-binding protein MECP2.
###end article-title 58
###begin article-title 59
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 59
###begin article-title 60
WHAP: haplotype-based association analysis.
###end article-title 60
###begin article-title 61
Functions for DNA methylation in vertebrates.
###end article-title 61
###begin article-title 62
The prevalence and incidence of Rett syndrome in Australia.
###end article-title 62
###begin article-title 63
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
###end article-title 63
###begin article-title 64
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.
###end article-title 64
###begin article-title 65
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3.
###end article-title 65
###begin article-title 66
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Reversal of neurological defects in a mouse model of Rett syndrome.
###end article-title 66
###begin article-title 67
MECP2 structural and 3'-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism.
###end article-title 67
###begin article-title 68
Mechanisms of disease: neurogenetics of MeCP2 deficiency.
###end article-title 68
###begin article-title 69
DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG.
###end article-title 69
###begin article-title 70
Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2.
###end article-title 70
###begin article-title 71
Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity.
###end article-title 71
###begin article-title 72
###xml 28 33 <span type="species:ncbi:9606">human</span>
Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation.
###end article-title 72
###begin p 73
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 73
###begin p 74
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This publication was made possible by NIH Grant Number P20-RR015577 from the National Center for Research Resources and by funding from the University of Oklahoma College of Medicine (AHS), NIH Grant Number AI63622 (SKN), and NIH Grants Number AR42460, AI024717, AI31584, AR62277, AR048940, AR0490084, Kirkland Scholar award, Alliance for Lupus Research, and the U.S. Department of Veterans Affairs (JBH).
###end p 74

